Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Margaret Curnutte"'
Autor:
Margaret Curnutte
Publikováno v:
New Genetics and Society, Vol 36, Iss 3, Pp 209-226 (2017)
In February 2015, 23andMe received clearance from the United States Food and Drug Administration (FDA) for a carrier status test for a gene linked to Bloom syndrome. This was the first FDA authorization to market a direct-to-consumer (DTC) genetic te
Externí odkaz:
https://doaj.org/article/14f4718fcd9f45f6920977fc23d4ad52
Autor:
Subhashini Chandrasekharan, Donna A. Messner, Jennifer Al Naber, Gail H. Javitt, Robert Cook-Deegan, Rachel Dvoskin, Amy L. McGuire, Margaret Curnutte, Mary A. Majumder, Juli Bollinger, Patricia A. Deverka, Pei P. Koay
Publikováno v:
Applied and Translational Genomics, Vol 10, Iss C, Pp 19-24 (2016)
Applied & Translational Genomics
Applied & Translational Genomics
This research aims to inform policymakers by engaging expert stakeholders to identify, prioritize, and deliberate the most important and tractable policy barriers to the clinical adoption of next generation sequencing (NGS). A 4-round Delphi policy s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8a70a720204a007cf28e21e21c77e8c
Autor:
Karen L Frumovitz, Amy L. McGuire, Robert Cook-Deegan, Mary A. Majumder, Margaret Curnutte, Juli Bollinger
Publikováno v:
Nature Biotechnology. 34:466-470
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f35fd48c2b3315e271f93fe6d6dbf93f
https://doi.org/10.1038/nbt.3545
https://doi.org/10.1038/nbt.3545
Publikováno v:
Nature Biotechnology. 35:22-24
The Broad Institute's recent licensing of its gene editing patent portfolio demonstrates how licenses can be used to restrict controversial applications of emerging technologies while society deliberates their implications.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c20f0b4155d1451a7e6586dd52bec057
https://doi.org/10.1038/nbt.3756
https://doi.org/10.1038/nbt.3756
Autor:
Rachel Dvoskin, Robert Cook-Deegan, Jennifer Al Naber, Amy L. McGuire, Mary A. Majumder, Gail H. Javitt, Margaret Curnutte, Pei P. Koay, Juli Bollinger, Donna A. Messner
Publikováno v:
Personalized medicine. 14(4)
Aim: Identify solutions to the most important policy barriers to the clinical adoption of next-generation sequencing. Materials & methods: Four-round modified policy Delphi with a multistakeholder panel of 48 experts. The panel deliberated policy sol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5ecb61f0b45868b7decd0647170fe79
https://pubmed.ncbi.nlm.nih.gov/29230253
https://pubmed.ncbi.nlm.nih.gov/29230253
Publikováno v:
Journal of Law, Medicine & Ethics. 42:5-8
In 1996, President Clinton offered a promissory vision for human genetics when he said: “I think it won't be too many years before parents will be able to go home from the hospital with their newborn babies with a genetic map in their hands that wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02ff13e735a02d846271035fceabd54e
https://doi.org/10.1111/jlme.12158
https://doi.org/10.1111/jlme.12158
Autor:
Margaret Curnutte
Publikováno v:
Contemporary Sociology: A Journal of Reviews. 44:862-864
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b976e15c48cdd26b0845f9a477b7649
https://doi.org/10.1177/0094306115609925yy
https://doi.org/10.1177/0094306115609925yy
Autor:
Giuseppe Testa, Margaret Curnutte
Publikováno v:
New Genetics and Society. 31:159-181
Since 2006 companies in the US have started to offer direct-to-consumer (DTC) genetic testing for a variety of diseases and traits. Recently, the activities of 23andMe and Navigenics, the two leading providers of DTC genetic services, have come under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89c23545445888e882251f4ca50cc98f
https://doi.org/10.1080/14636778.2012.662032
https://doi.org/10.1080/14636778.2012.662032
Publikováno v:
Nature biotechnology. 32(10)
Development of the clinical next-generation sequencing industry in a shifting policy climate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185276217bea62a2b4fa03fc279c3033
https://pubmed.ncbi.nlm.nih.gov/25299915
https://pubmed.ncbi.nlm.nih.gov/25299915